"
Team:British Columbia/Human Practices
From 2012.igem.org
Contents |
Intellectual Property
- Ask UBC tech transfer office
- Mike Gold suggested dropping his name to Ian Bell, Technology Transfer Manager for the Life Sciences
- Dr. Andre Marziali, EngPhys Director
- OSLI guidance?
- biobrick agreement
- [1]
Previous iGEM work
Survey questions for iGEM
Blurb about IP & patents.
- What experiences have you had with IP in iGEM?
- How did you approach the process?
- What resources did you use? Do you know how to find resources?
- What issues did you encounter?
- Have you consulted anyone outside of your team about IP?
- What would you like to have done to improve your experience?
- Do you have experience outside of iGEM?
- Has IP concerns affected your project? If so, how?
- What do you want to know about IP that we can help you with?
- Are you worried about the IP aspect of your project?
- Would you be interested in a FAQ about IP for iGEM?
- What type of format would you prefer? (e.g., video, FAQ page, "Choose your own adventure" walkthrough, etc.)
- Are you interested in protecting our own IP (e.g., through patenting)?
- Do you think Biobricks can be patented?
- Do you think iGEM teams can produce patentable projects?
- Do you think you can take your patent country to country easily?
- How much do you think patenting something costs?
- How much time do you think the patenting process would take?
- What is your main IP concern: Use of existing patents or establishing ownership of new patents?
- Do you know if your team's project depends on anything that is protected by IP rights?
- Do you think this would get in the way for patenting your own project?
- What aspect of dealing with IP would you like the most help with? What would you like to get out of a FAQ?
- How do you think IP protection affects innovation?
- Do you think IP protection and open source ideals can coexist?
- How does IP help/hurt your project?
Questions for Professionals
- What's a good rule of thumb for determining what things in biotechnology be patentable?
- Does that strongly vary among jurisdiction?
- What are particularly difficult jurisdictions to get patents in?
- What pitfalls might an iGEM team run into?
- Do you think it's worthwhile for iGEM teams to explore patenting for their projects? (ask Randy Retberg/iGEM HQ too)
- How do you think IP protection affects innovation?
- Is it generally worth getting a patent in just one country?
- How does the industry approach/handle patents held by researchers?
- How does IP help/hurt your project?
- How do you decide if something is worth patenting/licensing?
- What are the university's policies concerning ownership of researchers' work? How are they generally compared to other universities?
- How does the UILO/TTO help researchers reach their goals in getting IP protection?
- What happens when someone infringes a patent?
- What happens when someone doesn't give the university ownership of the IP? For example, if the researcher claims that he/she worked on it on their own time or at another institution?
- How does company sponsorship affect IP ownership?
- What are some typical problems researchers encounter?
Community Outreach
US/Canada Regulatory Concerns
- illegitimate DNA transfer (strains on band-aids in magazines?)
OSLI feedback
- Biosafety
- Efficiency
- Environmental
